Kerry Ettridge1, Joanna Caruso2, David Roder3, Ivanka Prichard4, Katrine Scharling-Gamba2, Kathleen Wright2, Caroline Miller5. 1. South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia. Kerry.ettridge@sahmri.com. 2. South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA, Australia. 3. University of South Australia, Adelaide, SA, Australia. 4. Caring Futures Institute, Flinders University, Adelaide, SA, Australia. 5. University of Adelaide, Adelaide, SA, Australia.
Abstract
PURPOSE: Collecting patient-reported outcomes is important in informing the well-being of women with breast cancer. Consumer perceptions are important for successful implementation of monitoring systems, but are rarely formally assessed. We compared reactions to two different surveys (assessing psychosocial outcomes and/or Health-related Quality of Life (HrQoL) outcomes) among Australian women with breast cancer. METHODS: Women (18 + years) within 5 years diagnosis of breast cancer were randomly allocated to complete one of two online surveys: (i) minimum HrQoL measures or (ii) minimum HrQoL measures plus psychosocial outcomes (body image, depression, anxiety stress, fear of cancer recurrence, decisional difficulties and unmet need). Participants completed questions regarding their perceptions of the survey, including qualitative feedback. RESULTS: Data were available for 171 participants (n(i) = 89; n(ii) = 82), with 92% (n = 158) providing 95-100% complete data. Perceptions were comparable between survey groups, and high (80-100%) regarding time burden, ease of completion, comprehensible, appropriateness and willingness to participate again and moderately high (67-74%) regarding willingness to answer more questions and relevance. Qualitative feedback indicated gaps across both surveys, including financial/work-related issues, satisfaction with information and care, need for nuanced questions, and impact of side effects/treatment, and from the minimum set only, emotional well-being and support. Impairment in some HrQoL and psychosocial outcomes were observed among participants. CONCLUSIONS: Assessment of HrQoL and psychosocial outcomes was well received by consumers. Results alleviate concern regarding possible patient burden imposed by longer more in-depth surveys. The importance placed on assessment brevity should not outweigh the need to assess outcomes that consumers consider important.
PURPOSE: Collecting patient-reported outcomes is important in informing the well-being of women with breast cancer. Consumer perceptions are important for successful implementation of monitoring systems, but are rarely formally assessed. We compared reactions to two different surveys (assessing psychosocial outcomes and/or Health-related Quality of Life (HrQoL) outcomes) among Australian women with breast cancer. METHODS: Women (18 + years) within 5 years diagnosis of breast cancer were randomly allocated to complete one of two online surveys: (i) minimum HrQoL measures or (ii) minimum HrQoL measures plus psychosocial outcomes (body image, depression, anxiety stress, fear of cancer recurrence, decisional difficulties and unmet need). Participants completed questions regarding their perceptions of the survey, including qualitative feedback. RESULTS: Data were available for 171 participants (n(i) = 89; n(ii) = 82), with 92% (n = 158) providing 95-100% complete data. Perceptions were comparable between survey groups, and high (80-100%) regarding time burden, ease of completion, comprehensible, appropriateness and willingness to participate again and moderately high (67-74%) regarding willingness to answer more questions and relevance. Qualitative feedback indicated gaps across both surveys, including financial/work-related issues, satisfaction with information and care, need for nuanced questions, and impact of side effects/treatment, and from the minimum set only, emotional well-being and support. Impairment in some HrQoL and psychosocial outcomes were observed among participants. CONCLUSIONS: Assessment of HrQoL and psychosocial outcomes was well received by consumers. Results alleviate concern regarding possible patient burden imposed by longer more in-depth surveys. The importance placed on assessment brevity should not outweigh the need to assess outcomes that consumers consider important.
Entities:
Keywords:
Breast cancer; Consumer perspectives; Health-related quality of life (HrQoL); Patient-reported outcome measures (PROMs); Psychosocial
Authors: M Lagendijk; L S E van Egdom; F E E van Veen; E L Vos; M A M Mureau; N van Leeuwen; J A Hazelzet; H F Lingsma; L B Koppert Journal: Ann Surg Oncol Date: 2018-09-03 Impact factor: 5.344
Authors: Wee Loon Ong; Maartje G Schouwenburg; Annelotte C M van Bommel; Caleb Stowell; Kim H Allison; Karen E Benn; John P Browne; Rodney D Cooter; Geoff P Delaney; Francois P Duhoux; Patricia A Ganz; Patricia Hancock; Reshma Jagsi; Felicia M Knaul; Anne M Knip; Linetta B Koppert; Henry M Kuerer; Sarah McLaughin; Marc A M Mureau; Ann H Partridge; Dereesa Purtell Reid; Lisa Sheeran; Thomas J Smith; Mark J Stoutjesdijk; Marie Jeanne T F D Vrancken Peeters; Yvonne Wengström; Cheng-Har Yip; Christobel Saunders Journal: JAMA Oncol Date: 2017-05-01 Impact factor: 31.777
Authors: Astrid Przezdziecki; Kerry A Sherman; Andrew Baillie; Alan Taylor; Elizabeth Foley; Kellie Stalgis-Bilinski Journal: Psychooncology Date: 2012-12-02 Impact factor: 3.894